Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Clear Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)WithdrawnNCT07084909
What this trial is testing

Piflufolastat F 18 PET/CT in Patients With Suspected, or at High Risk for Metastatic ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Lantheus Medical Imaging
Testing effectiveness (Phase 2)Active Not RecruitingNCT06035224
What this trial is testing

Cadonilimab (AK104) Plus Lenvatinib in Previously Immunotherapy-Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
RenJi Hospital 28
Testing effectiveness (Phase 2)Study completedNCT01097746
What this trial is testing

First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CarcinomaFallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid Adenocarcinoma+24 more
M.D. Anderson Cancer Center 33
Testing effectiveness (Phase 2)UnknownNCT02866370
What this trial is testing

Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium

Who this might be right for
Ovarian Clear Cell CarcinomaEndometrial Clear Cell Carcinoma
NHS Greater Glasgow and Clyde 120
Testing effectiveness (Phase 2)Ended earlyNCT01216371
What this trial is testing

Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)

Who this might be right for
Renal Cell CarcinomaPulmonary Metastases
Association of Urologic Oncology (AUO) 60
Testing effectiveness (Phase 2)UnknownNCT06129955
What this trial is testing

Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Looking for participantsNCT06447103
What this trial is testing

An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaSarcomatoid Renal Cell CarcinomaStage II Renal Cell Cancer+2 more
Jonsson Comprehensive Cancer Center 91
Early research (Phase 1)Active Not RecruitingNCT02142803
What this trial is testing

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Who this might be right for
Adult GlioblastomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+21 more
National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04065269
What this trial is testing

ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss

Who this might be right for
Gynaecological Cancers
Institute of Cancer Research, United Kingdom 174
Testing effectiveness (Phase 2)Looking for participantsNCT04977453
What this trial is testing

GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorCervical Cancer+3 more
GI Innovation, Inc. 317
Testing effectiveness (Phase 2)Ended earlyNCT04779151
What this trial is testing

Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab

Who this might be right for
Urothelial Bladder CancerGastric AdenocarcinomaGastro-oesophageal Adenocarcinoma+5 more
Gustave Roussy, Cancer Campus, Grand Paris 51
Testing effectiveness (Phase 2)Looking for participantsNCT07188896
What this trial is testing

Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)

Who this might be right for
Advanced Renal Cell Carcinoma (aRCC)Metastatic Renal Cell Carcinoma ( mRCC)Clear Cell Renal Cell Carcinoma (ccRCC)
Brian Rini 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06976021
What this trial is testing

Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy

Who this might be right for
Triple Negative Breast CancerUterine Cervical CancerUterine Corpus Cancer+2 more
Maria Sklodowska-Curie National Research Institute of Oncology 60
Post-approval studies (Phase 4)Study completedNCT00006864
What this trial is testing

Interleukin-2 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802876
What this trial is testing

Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors

Who this might be right for
MSI-H Colorectal CancerMelanomaAnal Carcinoma+28 more
SOLTI Breast Cancer Research Group 184
Testing effectiveness (Phase 2)Study completedNCT00770185
What this trial is testing

Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer

Who this might be right for
Endometrial Cancer
NCIC Clinical Trials Group 35
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07793318
What this trial is testing

TR115 in ARID1A-Mutated Advanced Solid Tumors

Who this might be right for
Ovarian Clear Cell CarcinomaEndometrial CancerStomach Cancer Recurrent+1 more
Tarapeutics Science Inc. 50
Large-scale testing (Phase 3)Active Not RecruitingNCT02811861
What this trial is testing

Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Eisai Inc. 1,069
Not applicableLooking for participantsNCT06916624
What this trial is testing

Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)Clear Cell Renal Cell Carcinoma (ccRCC)
The Affiliated Hospital of Qingdao University 120
Large-scale testing (Phase 3)Looking for participantsNCT07002346
What this trial is testing

INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell Carcinoma

Who this might be right for
Ovarian Clear Cell Carcinoma
Tongji Hospital 226
Next Page